Literature DB >> 16175681

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

.   

Abstract

Hypertensive disease occurs in approximately 12-22% of pregnancies, and it is directly responsible for 17.6% of maternal deaths in the United States (1,2). However, there is confusion about the terminology and classification of these disorders. This bulletin will provide guidelines for the diagnosis and management of hypertensive disorders unique to pregnancy (ie, preeclampsia and eclampsia), as well as the various associated complications. Chronic hypertension has been discussed elsewhere (3).

Entities:  

Mesh:

Year:  2002        PMID: 16175681     DOI: 10.1016/s0029-7844(01)01747-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  428 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

2.  Preeclampsia and retinopathy of prematurity in preterm births.

Authors:  Xiao Dan Yu; D Ware Branch; S Ananth Karumanchi; Jun Zhang
Journal:  Pediatrics       Date:  2012-06-04       Impact factor: 7.124

3.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

4.  Study of Nitrosative Stress in 'Pregnancy Induced Hypertension'.

Authors:  Kapila B Gaikwad; Nitin G Joshi; Sohan P Selkar
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 5.  Pharmacogenetics and individualizing drug treatment during pregnancy.

Authors:  David M Haas
Journal:  Pharmacogenomics       Date:  2014-01       Impact factor: 2.533

6.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

7.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

8.  Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women.

Authors:  Judette Louis; Dennis Auckley; Branko Miladinovic; Anna Shepherd; Patricia Mencin; Deepak Kumar; Brian Mercer; Susan Redline
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

9.  Human Placenta Expresses α2-Adrenergic Receptors and May Be Implicated in Pathogenesis of Preeclampsia and Fetal Growth Restriction.

Authors:  Hanaa K B Motawea; Maqsood A Chotani; Mehboob Ali; William Ackerman; Guomao Zhao; Amany A E Ahmed; Catalin S Buhimschi; Irina A Buhimschi
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

10.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.